Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
28
Bearish filings
1
Named actors
12
Disclosed $ (bull / bear)
$132.2M + 5 of unknown size / size unknown
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-11-13 | 5%+ holder (13G) Li Zhen | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-10-16 | 5%+ holder (13G) LAV Biosciences Fund V, L.P. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-10-05 | Activist (13D) SR ONE CAPITAL MANAGEMENT, LLC | disclosed an activist stake (13D) | — | SEC ↗ |
| 2026-10-02 | Activist (13D) ORBIMED ADVISORS LLC | disclosed an activist stake (13D) | — | SEC ↗ |
| 2026-10-01 | 5%+ holder (13G) BCLS Fund III Investments, LP | disclosed a passive stake (13G) | — | SEC ↗ |
4 more disclosures in the window — the full record, scoring, and track-record evidence are for members.
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-09-28 | Director OrbiMed Genesis GP LLC | bought | $5.1M | SEC ↗ |
| 2026-09-28 | Director OrbiMed Advisors Israel II Ltd | bought | $10.0M | SEC ↗ |
| 2026-09-28 | Director OrbiMed Advisors Israel II Ltd | bought | $5.1M | SEC ↗ |
| 2026-09-28 | Director OrbiMed Israel GP II, L.P. | bought | $10.0M | SEC ↗ |
| 2026-09-28 | Director OrbiMed Israel GP II, L.P. | bought | $1.0M | SEC ↗ |
| 2026-09-28 | Director ORBIMED ADVISORS LLC | bought | $10.0M | SEC ↗ |
| 2026-09-28 | Director OrbiMed Genesis GP LLC | bought | $1.0M | SEC ↗ |
| 2026-09-28 | Director OrbiMed Advisors Israel II Ltd | bought | $1.0M | SEC ↗ |
| 2026-09-28 | Director OrbiMed Genesis GP LLC | bought | $10.0M | SEC ↗ |
| 2026-09-28 | Director OrbiMed Capital GP VII LLC | bought | $10.0M | SEC ↗ |
| 2026-09-28 | Director OrbiMed Israel GP II, L.P. | bought | $5.1M | SEC ↗ |
| 2026-09-28 | Director OrbiMed Capital GP VII LLC | bought | $1.0M | SEC ↗ |
| 2026-09-28 | Director OrbiMed Capital GP VII LLC | bought | $5.1M | SEC ↗ |
| 2026-09-28 | Director ORBIMED ADVISORS LLC | bought | $5.1M | SEC ↗ |
| 2026-09-28 | Director ORBIMED ADVISORS LLC | bought | $1.0M | SEC ↗ |
| 2026-09-28 | Director GORDON CARL L | bought | $1.0M | SEC ↗ |
| 2026-09-28 | Director GORDON CARL L | bought | $10.0M | SEC ↗ |
| 2026-09-28 | Director GORDON CARL L | bought | $5.1M | SEC ↗ |
| 2026-09-28 | Director Chimovits Erez | bought | $1.0M | SEC ↗ |
| 2026-09-28 | Issuer (share issuance) | priced an offering | — | SEC ↗ |